JPRN-UMIN000008210招募中未知
Safety and efficacy of Tranilast for the treatment of relapsed or resistant lymphoid tumors; a pilot study - Tranilast for lymphoid tumors; a pilot study
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1, Allergy to Tranilast 2, Severe uncontrollable diabetes or infection 3, Active double cancers 4, Pregnant or lactating women or women of childbearing potential 5, AST,ALT>5xULN, T-Bil 3XULN 6, Cre>3xULN 7, Psychosis 8, Inadequate condition as diagnosed by primary physician
研究者
相似试验
已完成
不适用
Evaluation of safety and efficacy of tranilast in preventing graft-versus-host disease after allogeneic hematopoietic stem cell transplantatioPaients aged 20 years or greater who undergo allogeneic hematopoietic stem cell transplatation from an unrelated donorJPRN-UMIN000016401Keio University School of Medicine40
招募中
不适用
Evaluation of preventive effect of tranilast on esophageal stricture after extensive endoscopic submucosal dissection (ESD) therapy for superficial esophageal cancer.superficial esophageal cancerJPRN-UMIN000002741Division of Gastroenterology, Tohoku University Hospital30
进行中（未招募）
2 期
Efficacy and safety of Tiprelestat for treatment of severe COVID-19 (COMCOVID trial)COVID-19 hospitalized for COVID-19 treatment with score 4 or 5 according to WHO COVID-19 clinical progression scaleDRKS00031463tiakis Biotech AG17
进行中（未招募）
1 期
Efficacy and safety of Tiprelestat for treatment of severe COVID-19 (COMCOVID trial)Adult patients with COVID-19 fulfilling the following criteria:-First laboratory-confirmation of the current episode of SARS-CoV-2 infection (COVID-19) as determined by PCR or antigen test (no self tests) in any defined specimen collected within 10 days prior to trial enrolment.-Hospitalization for COVID-19 treatment.-Without or with oxygen therapy by mask/nasal prong (score 4 or 5 according to WHO COVID-19 clinical progression scale).MedDRA version: 23.1Level: LLTClassification code 10084401Term: COVID-19 respiratory infectionSystem Organ Class: 100000004862EUCTR2022-000714-33-DEtiakis Biotech AG (formerly Proteo Biotech AG)296
已完成
不适用
To Compare The Effect Of Transversus Abdominis Plane Block With Diclofenac Sodium And Diclofenac Sodium Alone After Cesarean Section.CTRI/2018/04/013252Govt Medical College Bhavnagar60